Dexmedetomidine and Agitation After Nasal Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorFayoum University Hospital
About this trial
The main objective of study is to compare dexmedetomidine single bolus dose before extubation with continuous infusion as regards their efficacy in mitigating the incidence of emergence agitation in obese adults undergoing nasal surgery.
Eligibility criteria
Qualifiers
American Society of Anesthesiologist (ASA) Ⅰ or II
Adults with body mass index (BMI) < 30 Kg/m
Underwent elective nasal surgery.
Disqualifiers
Significant comorbidity like hepatic, renal, or cardiac disease
Auditory impairment
Cognitive dysfunction
Substance abuse
Trial design
Treatments tested in this trial
- Dexmedetomidine in 0.9 % NaCl 1,000 Mcg/250 mL (4 Mcg/mL) INTRAVEN INFUSION BOTTLE (ML)
- Dexmedetomidine Injection [Precedex]
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov